T Cells Immune Imbalance Present in Patients With Multiple Intracranial Aneurysms

• Published in: Clinical and experimental immunology
• Main Authors: Tao, Chuming, Liu, Chenglong, Ge, Peicong, Chan, Liujia, Pang, Yuheng, Li, Junsheng, He, Qiheng, Liu, Wei, Mou, Siqi, Zheng, Zhiyao, Zhang, Bojian, Zhao, Zhikang, Sun, Wei, Zhang, Qian, Wang, Rong, Zhang, Yan, Wang, Wenjing, Zhang, Dong, Zhao, Jizong
• Format: Journal Article
• Language: English
• Published: England 11.07.2024
• Subjects: multiple intracranial aneurysms; circulating immune cell; mass cytometry; landscape
• ISSN: 1365-2249; 1365-2249
• DOI: 10.1093/cei/uxae058

Growing evidence suggests that systemic immune and inflammatory responses may play a critical role in the formation and development of aneurysms. Exploring the differences between single intracranial aneurysm (SIA) and multiple IAs (MIAs) could provide insights for targeted therapies. However, there is a lack of comprehensive and detailed characterization of changes in circulating immune cells in MIAs. Peripheral blood mononuclear cell (PBMC) samples from patients with SIA (n = 16) or MIAs (n = 6) were analyzed using high-dimensional mass cytometry to evaluate the frequency and phenotype of immune cell subtypes. A total of 25 cell clusters were identified, revealing that the immune signature of MIAs included cluster changes. Compared to patients with SIA, patients with MIAs exhibited immune dysfunction and regulatory imbalance in T-cell clusters. They also had reduced numbers of CD8+ T cells and their subgroups CD8+ Te and CD8+ Tem cells, as well as reduced numbers of the CD4+ T-cell subgroup CD27-CD4+ Tem cells. Furthermore, compared to SIA, MIAs were associated with enhanced T-cell immune activation, with elevated expression levels of CD3, CD25, CD27, CCR7, GP130, and interleukin 10. This study provides insights into the circulating immune cell profiles in patients with MIAs, highlighting the similarities and differences between patients with SIA and those with MIAs. Furthermore, the study suggests that circulating immune dysfunction may contribute to development of MIAs.